Search Results - "Lan, Naiying"

Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report by Yang, Bo, Gou, Wei, Lan, Naiying, Shao, Qing, Hu, Weifeng, Xue, Cheng, Liu, Nanmei

“…Tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody has been approved in China and Europe. According to the published clinical research, tislelizumab…”
Get full text

External validation of a novel nomogram for diagnosis of Protein Energy Wasting in adult hemodialysis patients by Yan, Danying, Wang, Yi, Hu, Jing, Lu, Renhua, Ye, Chaoyang, Liu, Nanmei, Chen, Dongping, Liang, Weiwei, Zheng, Liang, Liu, Wenrui, Lan, Tianying, Lan, Naiying, Shao, Qing, Zhuang, Shougang, Ma, Xiaoyan, Liu, Na

“…Protein Energy Wasting (PEW) has high incidence in adult hemodialysis patients and refers to a state of decreased protein and energy substance. It has been…”
Get full text

Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report by Yang, Bo, Gou, Wei, Lan, Naiying, Shao, Qing, Hu, Weifeng, Xue, Cheng, Liu, Nanmei

“…BackgroundTislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody has been approved in China and Europe. According to the published clinical research,…”
Get full text